CSRT.L Regulatory News (CSRT)

Consort Medical plc

Director/PDMR shareholding

19 June 2014

Consort Medical plc (the 'Company') announces that the undermentioned directors and other persons discharging managerial responsibilities, ('PDMRs'), have received shares under the terms of the Consort Medical plc Deferred Bonus Plan ('DBP').

The shares vested on 15 June 2014 for nil consideration pursuant to an Award made on 1 August 2011 and were exercised by the individuals on 18 June 2014 within the 40 day period allowed for the exercise of options and following the announcement of the Company's preliminary results.

The exercise of the options was satisfied out of the ordinary shares held in the Consort Medical plc Employee Share Ownership Trust.

The disposals referred to below were made on 18 June 2014 at £8.72 per share and were sold to cover tax liabilities.

The Company was informed of the above transactions on 18 June 2014.

Enquiries: R Cotton 01442 867920

Consort Medical plc is an international medical devices company, focused on developing and manufacturing disposable medical devices for drug delivery. The principal business of the Company is the management of Bespak, a global market leader in the manufacture of drug delivery devices for pharmaceutical partner companies, including respiratory, nasal, and injectables products, and the manufacture of devices for the point of care diagnostics market.

The Group has facilities in King's Lynn, Cambridge, Nelson, Milton Keynes and Hemel Hempstead in the UK. Consort Medical is a public company quoted on the full list of the London Stock Exchange (LSE: CSRT). The Group's website address is www.consortmedical.com.